$61.64
-1.28 (-2.03%)
Performance
1D
—
1W
—
1M
—
3M
-38.61%
6M
-27.58%
1Y
+75.11%
YTD
-30.64%
Open$62.89
Previous Close$62.92
Day High$63.00
Day Low$60.58
52W High$118.84
52W Low$29.95
Volume—
Avg Volume631.7K
Market Cap2.58B
P/E Ratio—
EPS$-11.18
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$97.75
Below
SMA 200
$64.49
Below
RSI (14)
50.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
12 analysts
Price Target
-45.5% upside
Current
$61.64
$61.64
Target
$33.59
$33.59
$28.45
$33.59 avg
$56.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 167.67M | 121.17M | 2.02B |
| Net Income | -465,219,634 | -302,592,809 | 154.03M |
| Profit Margin | -277.5% | -263.6% | 7.6% |
| EBITDA | -489,044,842 | -335,761,075 | 214.07M |
| Free Cash Flow | — | — | 137.52M |
| Rev Growth | +38.4% | +38.4% | +15.5% |
| Debt/Equity | — | — | 0.96 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |